Indoco Remedies announced today that the UK Medicines and Healthcare Products Regulatory Agency (UKMHRA) inspected its solid dosages manufacturing facility in Goa (Plant I) from 07 September to 09 September 2026. The UK-MHRA current Good Manufacturing Practices (cGMP) inspection concluded with no critical or major observations.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.